HPC › Nutrition › Glossary
mTOR (mechanistic Target of Rapamycin) is a serine/threonine protein kinase that functions as the cell's central growth-and-recycling switch. It integrates signals from amino acids, insulin, glucose, and cellular energy status to either drive protein synthesis, ribosome biogenesis, and cell growth, or, when nutrients are scarce, to suppress anabolism and activate autophagy, the cellular self-cleaning programme.
The kinase assembles into two distinct complexes: mTORC1, the nutrient-sensitive growth driver, and mTORC2, which governs cell survival and cytoskeletal organisation.
How it works
mTOR assembles into two distinct multiprotein complexes with separate roles 32. mTORC1 is the primary nutrient-sensitive complex: when active, it phosphorylates downstream effectors S6K1 and 4EBP1 to stimulate protein synthesis, ribosome biogenesis, lipid production, and cell growth. mTORC2, the second complex, regulates cell survival and cytoskeletal organisation and responds far less acutely to fluctuations in nutrient availability.
Amino acids, particularly leucine and arginine, are the most potent activators of mTORC1 3. They are sensed by upstream protein complexes, including Sestrins, CASTOR proteins, and the GATOR1/GATOR2 super-complex, which regulate Rag GTPases that recruit mTORC1 to the lysosomal surface for activation. Think of the lysosome as an operational checkpoint: mTORC1 commits to the energy-expensive work of cell growth only once it receives confirmation that both amino acid supply and energy status are adequate.
Active mTORC1 phosphorylates and inhibits ULK1, the kinase that initiates autophagy, suppressing cellular recycling whenever nutrients are plentiful 24. When fasting withdraws amino acid and insulin signals, mTORC1 disengages from the lysosomal surface; the withdrawal lifts the brake on ULK1, restarting autophagy and enabling the cell to recycle damaged organelles and reclaim amino acids from macromolecular breakdown. TOR itself was first identified in Saccharomyces cerevisiae through screens for rapamycin resistance, revealing a nutrient-sensing master regulator conserved across all eukaryotes 1.
Example
An athlete completes a resistance training session, which primes skeletal muscle for mTORC1 activation. Consuming a leucine-rich protein source within an hour supplies the specific amino acid signal that drives Rag GTPase activity, recruits mTORC1 to the lysosomal surface, and unlocks a burst of muscle protein synthesis, capitalising on the exercise-induced sensitivity to maximise the anabolic response.
The timing precision reflects the biology: mTOR activates only when both the mechanical training signal and the amino acid signal converge at the lysosomal sensor.
Why it matters
Chronic mTOR overactivation, sustained by persistent nutrient surplus, obesity, or oncogenic mutations, is implicated in cancer progression, insulin resistance, type 2 diabetes, and neurodegeneration 23. Appropriate mTOR inhibition through dietary cycling or caloric restriction is associated with longevity benefits across model organisms, suggesting that the physiological advantage lies not in constant mTOR activity but in the disciplined alternation between growth and recycling phases.
Rapamycin and its clinical derivatives, the rapalogs, were discovered directly from the original yeast TOR screens and are now approved immunosuppressants and oncology therapeutics 13. Nutritional cycling through intermittent fasting creates a deliberate mTOR on/off pattern: the fasting window activates autophagy and cellular repair, while the feeding window restores mTORC1-driven protein synthesis 42. For performance-oriented individuals, grasping this cycling logic transforms fasting and protein timing from habit choices into mechanistically grounded interventions.
What activates mTOR?+
mTORC1 is activated primarily by amino acids, particularly leucine and arginine. They are sensed by upstream complexes including Sestrins, CASTOR proteins, and GATOR1/GATOR2, which regulate Rag GTPases that recruit mTORC1 to the lysosomal surface for activation. Insulin and cellular energy status feed in as secondary inputs, making mTORC1 a multi-signal integrator rather than a simple on/off switch.
Does fasting suppress mTOR?+
Fasting reduces mTORC1 activity by withdrawing the two inputs that sustain it: amino acids and insulin. As mTORC1 disengages from the lysosomal surface, it releases ULK1 from inhibition, initiating autophagy. A fasting window therefore acts as a deliberate recycling phase, clearing damaged cellular components before mTORC1 is re-activated by the next feeding period.
Is high mTOR activity good or bad for health?+
Context determines the answer. Acute mTOR activation after training or feeding supports muscle protein synthesis and tissue repair. Chronic mTOR overactivation, driven by persistent caloric surplus or oncogenic mutation, is implicated in cancer, insulin resistance, and metabolic disease. The same kinase that builds muscle can drive tumour growth when it loses the cycling pattern it evolved for.
How does leucine activate mTOR?+
Leucine is the primary amino acid trigger for mTORC1. After absorption, it signals through Sestrin proteins and the GATOR1/GATOR2 complex to activate Rag GTPases at the lysosomal surface, recruiting mTORC1 to its activation site where it phosphorylates S6K1 and 4EBP1. Leucine-rich sources such as whey and animal proteins produce the most potent mTORC1 dietary response.
